2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Pertussis Vaccine Market?

The surge in birth rates is a key factor propelling the advancement of the pertussis vaccine market. The act of giving birth, known as childbirth, marks the culmination of pregnancy, as the fetus in the womb prepares for a life beyond. The pertussis vaccine primarily shields children from diseases like whooping cough that could prove to be fatal. For example, a report from the US-based Centers for Disease Control and Prevention in January 2023 disclosed that the number of registered births in the United States climbed by 1% from the year before, reaching a total of 3,664,292. So, the escalating birth rates are fueling the enlargement of the pertussis vaccine market. Growth in the pertussis vaccine market can be attributed to the rise in geriatric population, defined as individuals 65 years and older. As the life expectancy grows higher, so does the demand for the pertussis vaccine, to safeguard the elderly from this grave illness. For instance, the World Health Organization projected in October 2022 that the global count of those aged 60 and above would double by 2050, hitting 2.1 billion. Furthermore, the number of people aged 80 and over is expected to triple from 2020 to 2050, reaching 426 million. This uptick in the aging population is therefore driving the expansion of the pertussis vaccine market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What is the Predicted Annual Growth Rate of thePertussis Vaccine Market Impact Industry Trends by 2034?

The size of the pertussis vaccine market has been expanding consistently over the past few years. It is projected to rise from $5.5 billion in 2024 to $5.72 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%. Factors such as disease occurrence, immunization initiatives, childhood vaccination, and regulatory sanctions have contributed to the growth during the historic period.

Expectations point towards a steady expansion in the pertussis vaccine market in the coming years. Forecasts predict the market value will reach $6.62 billion in 2029, experiencing a compound annual growth rate (CAGR) of 3.7%. This growth over the forecast period is largely due to factors such as booster vaccination, maternal immunization, immunization initiatives for healthcare workers, and global health initiatives. The key trends projected to shape this period include personalized immunization schedules, combination vaccines, initiatives for vaccine equity, and the use of digital health in immunization.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

What New Market Trends Are Reshaping thePertussis Vaccine Market and Its Opportunities?

Key players in the pertussis vaccine market are innovating and gaining clearances to secure their market standing. For example, in October 2022, the U.K.-based pharmaceutical and biotech firm, GSK plc., announced the approval of BOOSTRIX by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a Tdap vaccine, i.e., a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed, administered during pregnancy to safeguard newborns from whooping cough. It is injected once in the upper arm muscle. Boostrix is both safe and effective for expectant mothers and their newborns. Moreover, it effectively guards against whooping cough, even in severe instances.

Who Are the Leading Market Players Fueling Growth in the Pertussis Vaccine Market Trend?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

How is the Global Pertussis Vaccine Market Segemented?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Which Geographics are Influencing the Growth of the Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Pertussis Vaccine Market 2025, By The Business Research Company:

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Meningococcal Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: